Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
The full text of a review entitled “Fruit and vegetables and cancer risk” is available on the web site of the British Journal of Cancer, and it is not good news.
Filed under: Diagnosis, Prevention, Risk | Tagged: cancer, fruit, Prevention, risk, vegetable | 3 Comments »
There are a lot of media reports today about a protein called Bmi-1 and its impact on the regulation and development of prostate cancer.
Filed under: Drugs in development | Tagged: Bmi-1, cell, growth, regulation | 2 Comments »
Back in July (Time to give the Daily Mail the finger) we commented on the strange hypothesis that differences in the lengths of fingers on the right hand might be an indicator of risk for prostate cancer.
Filed under: Diagnosis, Risk | Tagged: finger length, risk | 1 Comment »
Unfortunately — but far from unexpectedly — the Oncology Drugs Advisory Committee (ODAC) to the US Food & Drug Administration today voted against the approval of durasteride for the prevention of prostate cancer in men known to be at elevated risk.
Filed under: Living with Prostate Cancer, Prevention | Tagged: dutasteride, finasteride, Prevention | 6 Comments »
An article in today’s issue of the Journal of the American Medical Association, and the accompanying editorial in the same issue, are getting a lot of media attention — despite the fact that the article is “only” a mathematical analysis of the possible quality of life benefits of active surveillance in low-risk patients compared to [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, life expectancy, low risk | Leave a Comment »
A new study has suggested that, although the PCA3 test is slightly better than the total PSA test in prediction of risk for a positive biopsy finding, it is not necessarily always better than the free PSA test.
Filed under: Diagnosis, Risk | Tagged: biopsy, free, PCA3, positive, PSA, risk, total | 1 Comment »
An FDA advisory committee will meet today to review data on the potential use of dutasteride for the prevention of prostate cancer. The Prostate Cancer Roundtable (including Prostate Cancer International) issued the following media release yesterday.
Filed under: Prevention | Tagged: dutasteride, Prevention | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site